WHO Grade 1 Glioma — Trials

WHO Grade 1 Glioma — Trials · CancerIndex

Clinical trials

Registered studies

36 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01089101	Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma	active not recruiting	Phase 1 / Phase 2	217	National Cancer Institute (NCI)NIH	1	Sep 21, 2026	clinicaltrials
NCT04065776	Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma	active not recruiting	N/A	48	St. Jude Children's Research HospitalOTHER	1	Sep 15, 2026	clinicaltrials
NCT04166409	A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma	recruiting	Phase 3	170	National Cancer Institute (NCI)NIH	3	Sep 11, 2026	clinicaltrials
NCT03975829	Pediatric Long-Term Follow-up and Rollover Study

Data updated 5 days agoSource updated Sep 21, 2026source: clinicaltrials